150 results
8-K
EX-99.1
CVSI
CV Sciences, Inc.
28 Mar 24
CV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results
9:20am
with Streeterville (Q1 2023);
Reversed accrued payroll tax associated with RSU release to founder in 2019 due to the expiration of the statute of limitations … an operating income of $3.4 million in fiscal 2023, compared to an operating loss of $6.8 million in, mostly due to the reversal of accrued payroll tax of $6.2
8-K
EX-99.1
sgx eddsvmypt
14 Nov 23
CV Sciences, Inc. Reports Third Quarter 2023 Financial Results
12:00am
8-K
EX-99.1
250kvbc3uyl azocdi6h
14 Aug 23
CV Sciences, Inc. Reports Second Quarter 2023 Financial Results
9:32am
8-K
EX-10.1
5atlrah4tygnjw
5 Jun 23
Departure of Directors or Certain Officers
4:52pm
8-K
EX-99.1
yuat48gdn6ddyw0ky
15 May 23
CV Sciences, Inc. Reports First Quarter 2023 Financial Results
9:10am
8-K
EX-99.1
4ku71z9pqlurh5lh
14 Nov 22
CV Sciences, Inc. Reports Third Quarter 2022 Financial Results
9:12am
8-K
EX-10.3
3hta7k5k
24 Aug 22
Entry into a Material Definitive Agreement
7:04pm
8-K
EX-10.1
q68mmjq 4k
24 Aug 22
Entry into a Material Definitive Agreement
7:04pm